Phase I Study of Oral DFP-11207 in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology
- Status
- COMPLETED
- Phase
- N/A
MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With Trametinib and Dabrafenib in Participants With Advanced Melanoma (MK-3475-022/KEYNOTE-022)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Study of Chiauranib in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Investigator Initiated Phase 1 Study of TBI-1201
- Status
- COMPLETED
- Phase
- PHASE1
Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection
- Status
- COMPLETED
- Phase
- PHASE4
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Study of Eribulin in Children With Cancer to Determine Safety
- Status
- TERMINATED
- Phase
- PHASE1
Phase I Study of KPT330 in Asian Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Whey Protein Supplementation in Cancer Patients
- Status
- COMPLETED
- Phase
- NA
To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1